Fuse Medical Inc (FZMD) Inventory Turnover Ratio, from second quarter 2023 to second quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Fuse Medical Inc   (FZMD)
 

Fuse Medical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Fuse Medical Inc 's inventory turnover ratio, the ratio that measures Fuse Medical Inc 's ability to manage its supply chain, sequentially decreased to 0.63 in the second quarter 2023, which does not come as a surprise, as the Fuse Medical Inc continue to experience headwinds, which also impact its supply chain. Fuse Medical Inc 's average inventory processing period in the Jun 30 2023 quarter, has increased to 579 days, from 521 days, in the Mar 31 2023 quarter.

Within Healthcare sector 389 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2023, to 1608, from total ranking in the first quarter 2023 at 1660.

FZMD Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Fuse Medical Inc Market Share?

What is Inventory Turnover Ratio?




FZMD Inventory Turnover Ratio (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Inventory Growth -3.53 % -1.2 % 8.68 % 14.97 % 12.57 %
Y / Y Cost of Sales Growth -41.98 % -28.11 % -10.65 % -20.41 % -22.34 %
Inventory Turnover Ratio (TTM) 0.63 0.7 0.75 0.79 0.86
FZMD's Total Ranking # 1608 # 1660 # 1989 # 1865 # 2005
Average inventory processing period 578 520 488 460 423
Seq. Inventory Growth -1.38 % -3.59 % -3.62 % 5.27 % 1 %
Seq. Cost of Sales Growth -14.41 % -48.59 % 53.38 % -14.04 % 6.06 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 169
Healthcare Sector # 390
Overall Market # 1608

Inventory Turnover Ratio Statistics
High Average Low
21.13 3.64 0.63
(Sep 30 2017)   (Jun 30 2023)




Financial Statements
Fuse Medical Inc 's Inventories $ 9 Millions Visit FZMD's Balance sheet
Fuse Medical Inc 's Cost of Revenues TTM $ 6 Millions Visit FZMD's Income Statement
What are FZMD's Sales? Visit FZMD's Sales by Segment

Other Inventory Turnover Ratios
Fuse Medical Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
FZMD's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for FZMD's Competitors
Inventory Turnover Ratio for FZMD's Suppliers
Inventory Turnover Ratio for FZMD's Customers

You may also want to know
FZMD's Sales Growth Rates FZMD's Pe Price to earnings ratio FZMD's Receivables Turnover Ratio FZMD's Stock Quote
FZMD's Net Income Growth Rates FZMD's Ps Price to Sales ratio FZMD's Sales per Employee FZMD's Asset Turnover Ratio
FZMD's Net Margin FZMD's Pb Price to Book ratio FZMD's Financial Strength Ratios FZMD's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2023 Inventories at quarter ending Jun 30 2023
Lifeloc Technologies Inc   1.80 $ 5.039  Millions$ 3  Millions
Nature s Sunshine Products inc   1.80 $ 120.911  Millions$ 67  Millions
Hologic Inc  1.80 $ 1,199.300  Millions$ 667  Millions
Thermogenesis Holdings Inc   1.79 $ 6.427  Millions$ 4  Millions
Skinhealth Systems Inc   1.78 $ 199.023  Millions$ 112  Millions
Surmodics Inc   1.78 $ 23.523  Millions$ 13  Millions
Enovis Corp  1.77 $ 766.224  Millions$ 434  Millions
10x Genomics Inc   1.76 $ 139.000  Millions$ 79  Millions
Immucell Corporation  1.75 $ 11.014  Millions$ 6  Millions
Bio rad Laboratories Inc   1.74 $ 1,275.726  Millions$ 734  Millions
Stryker Corp  1.72 $ 7,240.000  Millions$ 4,201  Millions
Biogen Inc   1.72 $ 2,295.900  Millions$ 1,333  Millions
Encision Inc   1.72 $ 3.237  Millions$ 2  Millions
Karyopharm Therapeutics Inc   1.71 $ 6.819  Millions$ 4  Millions
Acutus Medical Inc   1.68 $ 24.589  Millions$ 15  Millions
Alnylam Pharmaceuticals Inc   1.67 $ 199.447  Millions$ 119  Millions
Y mabs Therapeutics inc   1.66 $ 11.228  Millions$ 7  Millions
Conmed Corporation  1.63 $ 529.587  Millions$ 325  Millions
Yunhong Green Cti Ltd   1.63 $ 13.461  Millions$ 8  Millions
Emergent Biosolutions Inc   1.61 $ 651.700  Millions$ 405  Millions
Accelerate Diagnostics Inc   1.59 $ 8.313  Millions$ 5  Millions
Neurometrix Inc   1.58 $ 2.374  Millions$ 2  Millions
Bruker Corporation  1.58 $ 1,312.700  Millions$ 831  Millions
Halozyme Therapeutics Inc   1.58 $ 174.679  Millions$ 111  Millions
Ligand Pharmaceuticals Incorporated  1.57 $ 30.114  Millions$ 19  Millions
Keenova Therapeutics Plc  1.57 $ 1,480.000  Millions$ 944  Millions
Anika Therapeutics Inc   1.57 $ 63.057  Millions$ 40  Millions
Neuropace Inc   1.56 $ 15.278  Millions$ 10  Millions
Acorda Therapeutics Inc   1.55 $ 21.864  Millions$ 14  Millions
Artivion Inc   1.55 $ 117.106  Millions$ 76  Millions

Date modified: 2023-08-16T12:05:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.